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ABSTRACT
Inflammatory bowel disease (IBD) is marked by inflammation mediated epithelialmucosal damage. The intestinal epithelial forms a tight barrier displaying two contrasting
functions: restricting the entry of potentially harmful substances while, on the other hand
allowing the selective passage of nutrients. The damaged epithelial-mucosal barrier causes the
exposure of mucosa layers to luminal inflammatory contents. This eventually leads to the leaky
epithelium, exposing the immune cells, release of various cytokines, and results in loss of
epithelial homeostasis. Therefore, maintenance of healthy epithelial- mucosal lining is critical
during IBD recovery. Notch signaling is an evolutionarily conserved molecular pathway crucial
for the development and homeostasis of most tissues. Notably, the deregulation of Notch
signaling is involved in IBD (Ulcerative colitis and Crohn’s disease). Notch signaling also plays a
vital role in wound healing and tissue repair. Here, we investigated the role of Notch-1 signaling
in wound healing and regeneration of colonic epithelium during colitis recovery phase by using
conditional deletion of Notch-1 in colonic epithelium of mice. We used colonic carcinoma cell
line HCT116 transiently transfected with Notch1 intracellular domain (NICD) to support in vivo
data. We observed that deletion of Notch1 among mice was associated with compromised
healing after colitis. Therefore, targeting the Notch-1 pathway might provide a novel
therapeutic strategy for the patients recovering from colitis.
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1 BACKGROUND
1.1 Inflammatory Bowel Disease
Inflammatory Bowel Diseases (IBD), represented by Crohn’s Disease (CD) and Ulcerative
Colitis (UC), are chronic and remitting disorders accountable for causing inflammation of the
gastrointestinal tract. Although IBD is not a fatal disorder, this condition is associated with
substantial patient burden and costs to health-care systems. Approximately 1.6 million people
are affected with IBD in, 785,000 with CD and 910,000 with UC [1]. Prevalence is greater in
developed western countries, with up to 2 million people suffering of these conditions in
Europe [2]. Interestingly, since the starting of 21st century newer epidemiologic studies have
shown the rising incidence of IBD in developing countries in South America, Asia, Africa and
Eastern Europe [2, 3]. The change in epidemiologic patterns in populations where IBD were not
previously common is hypothesized due to environmental factors and industrialization that are
involved in the development of these chronic inflammatory disorders. The increased prevalence
of IBD in specific populations is supposed to have a genetic component like NOD2 the first gene
to be associated with IBD [2, 3]. Most environmental triggers could mediate IBD pathogenesis
through their impact on the microbiome [3]. However, for microbial dysbiosis to take place and
continue inflammation, the integrity of the intestinal barrier separating the lumen and the
mucosa should also be compromised [4, 5].
1.2 Microbiome
The intestinal microbiome surfaced to establish the connection between the outside
environment and the intestinal mucosa. Microbial dysbiosis, as a result of decreased diversity
of the microbiome, has been displayed in IBD [6, 7]. Whether this is the cause or consequence
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of the observed intestinal inflammation, or both, is yet to be determined [7]. In IBD patients,
there is a decrease in commensal bacteria in contrast to pathogenic bacteria [7]. The major
observed changes include a decrease of Firmicutes and increase in Proteobacteria sp. and
Bacterioidetes sp [4]. The number of short-chain fatty acids producing bacteria like
Faecalibacterium prausnitzii has been shown to be decreased in IBD. In contrast, the increase in
Proteobacteria sp., most notably Escherichia coli, with the ability to adhere to the intestinal
epithelium affects the permeability of the intestine. Consequently, affecting differentiation and
expansion of Tregs as well as growth of epithelial cells [8].
Finally, over activation of the immune system, depends on the working
balance/dysregulation between effector and regulatory cells present in the intestinal mucosa
[9]. Therefore, it is the interplay of genetic susceptibility, environmental impact, microbiome,
and a weakened intestinal barrier which results in inappropriate immune activation responsible
for IBD (Fig. 1).

Figure 1. Mechanisms involved in the pathogenesis of IBD.
Interplay of genetic, environmental, weak intestinal barrier and dysregulated immune response are
responsible for IBD onset
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1.3 Intestinal Epithelial Cells
Intestinal epithelial cells (IECs) create a barrier between lumen and lamina propria of
colon, maintaining homeostasis in healthy individuals. Considering the notable load of daily
ingested foreign antigens and commensals, combined with the large number of lymphocytes
resident in the mucosa, the colon is predisposed for an inevitable dysregulation or malfunction.
However, despite these conditions, the normal state of the gut is splendidly maintained. A
frequent hallmark of inflamed tissue resected from CD and UC patients is the disruption of the
intestinal epithelium, either because of enhanced epithelial differentiation or de-differentiation
[9].
Generally, maintenance of the intestinal epithelium involves a dynamic process where
intestinal stem cells (ISCs), located at the crypt base undergo differentiation, proliferation, and
migration along the crypt-villus axis. Migration, and finally apoptosis/cell shedding are spatially
and temporally regulated along the crypt/surface axis in the colon. The stem cell populations
located at the bottom of the crypt proliferate and terminally differentiated into functional
absorptive, goblet, and enteroendocrine cells [10]. These processes are dysregulated in the
inflamed mucosa. More severe damage can instigate either total epithelial destruction and
ulceration or dysplasia and progressive tumorigenesis.
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Figure 2. Different layers of colonic mucosa depicting intestinal epithelium.
(Image adapted from American cancer society, colorectal cancer)

1.4 The Notch Signaling Pathway
The Notch signaling pathway regulates cell-fate decisions through close-range, cell–cell
interactions [11]. Notch-1, which is highly expressed in intestinal stem cells, up-regulates the
expression of the transcriptional repressor Hes-1, which in turn inhibits the expression of Atoh1, a basic helix-loop-helix transcription factor. Atoh-1 expressing progenitor cells differentiate
into secretory cells, while Hes-1 inhibited expression of Atoh-1 leads to absorptive cells [12].
The crypt is mainly composed of proliferative stem cells, poorly differentiated epithelial and
Paneth cells, whereas the top is lined with functional absorptive, goblet, and enteroendocrine
cells. Notch-1 is highly expressed in intestinal stem cells. The cleavage of Notch-1 leads to the
activation of downstream signal and transcription of target genes such as co activator and
mastermind protein complex which in turn activates Hes-1. The up-regulation of the
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transcriptional repressor Hes1 inhibits the expression of Atoh-1. Yang et al. [13] suggested that
Atoh-1 expression is needed for IECs to make the first lineage-specifying commitment. The
initial differentiation event in progenitor cells is affected by the position of the epithelial cells
along the crypt-villus axis and by their interactions with other neighboring cells [14]. Notch
pathway regulates the balance between the pool of absorptive versus secretory cells. Notch-1,2
or 4 is crucial for such homeostasis and there are no human mutations known in this gene so
far. Homozygous mice with loss of-function alleles for Notch-1 die between embryonic days 10
and 12 [15, 16].

Figure 3. The Notch signaling pathway and its inhibitors.
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Notch signaling is activated upon ligand (Delta or Jagged) binding to an adjacent Notch receptor on a
neighboring cell. Upon activation, Notch receptors are cleaved, first by ADAM, in the extracellular
domain (S2 cleavage). The released extracellular domain (NECD) is then trans-endocytosed by the
ligand-expressing cell. The second cleavage (S3 cleavage) is mediated by the γ-secretase (GS) complex,
which releases the Notch intracellular domain (NICD) into the cytoplasm, thus allowing its activation and
nuclear translocation. In the nucleus, NICD binds to the transcription factor CSL family proteins and the
Mastermind (MAM)-like transcriptional co-activator 1. The assemble of this transcription activation
complex on the recombination signal-binding protein for immunoglobulin kappa J (RBP-J) promoter
region, leads to the expression of various downstream target genes. The schematic was drawn using
BioRender (https://biorender.com).

The Notch signaling pathway is a critical component of fetal development but also has
been implicated in many disease processes, especially in colorectal carcinomas [17]. Moreover,
it has been suggested that the Notch pathway is involved in IBD pathogenesis as well [18].
Overexpression of the Notch signaling pathway exacerbate the inflammatory stimulus with a
decrease in goblet cells. Moreover, Watanabe’s group in Japan has published that doxycyclineinduced over-expression of Notch intracellular domain (NICD) in the LS174T goblet cell line
leads to an aberrant goblet cell phenotype [19]. Suppression of Atoh-1 is associated with goblet
cell depletion in UC. Cleaved Notch-1 (the activated form of Notch1/NICD) is shown to be upregulated in UC mucosa [20].

Figure 4. Colon Stem Cell Niche and Types of Epithelial Insults.
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The epithelium is compartmentalized in crypts. Right: Radiation induced injury damage is displayed,
including the compartments where they are most likely to induce injury and how different cell types
modulates the regeneration of stem cells. Damage by radiotherapy or acute inflammation is most
detrimental in the crypt region. Left: Zoom-in of a crypt with Lgr5+ stem cells that are intermingled with
Paneth like cells. Various cell types of secretory and absorptive cell lineages. (Image adapted from Eric
D. Bankaitis et. al, Gastroenterology AGA)

1.5 Tight Junctions’ Role in Maintaining Epithelial Barrier Function
The intestinal epithelial cell plasma membrane serves as an effective barrier to most
luminal contents through apical cell to cell barrier. However, the paracellular space must be
sealed to form an intact barrier. This seal is mediated by the tight junction (TJ) like claudins,
occludins, and Zona occludens (ZO) [21-23]. Connections between TJ proteins and cytoskeletal
elements stabilize the epithelial barrier function [24]. TJ permeability is often modulated by the
immune system [24]. It has been recently reported that RAG1-deficient mice have a
permeability defect in their distal colon, putatively associated with a decrease in the Notch-1
signaling pathway due to a lack of immune-epithelial cell crosstalk [20]. A significant decrease in
the trans-epithelial resistance (TER) when Notch-1 was knocked down was observed. Thus, the
accumulated evidence bolsters the concept that the Notch-1 signaling pathway is critical for IEC
differentiation and function. The absence of a Notch-1 signaling pathway dramatically increased
claudin-2 expression in vitro. Conversely, occludin expression was markedly decreased. The
effect on claudin-5 was quite insignificant but is interrelated with a cytoplasmic redistribution
of the protein [20]. Several studies have suggested that the accurate stoichiometry of the tight
junction complex is critical for optimal function [25]. Therefore, Notch-1 knocked down
arbitrates disruption of TJs stoichiometry that may account for the abnormal barrier function.
Altogether, these findings provide evidence for the involvement of the Notch-1 signaling
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pathway not merely in the architecture of the epithelium but correspondingly its barrier
function.

Figure 5. Paracellular intestinal barrier in healthy and inflamed colonic epithelial cells.
The paracellular barrier in healthy distal colon epithelium is characterized by high expression levels of
barrier-forming TJ proteins (claudins, occludins, and Zona occludens) which leads to a low paracellular
permeability. In inflammation, the TJ barrier is disturbed. Channel-forming claudins are up-regulated in
their expression (eg, by TNF-α or IL-12), leading to an increased permeability for ions and water (pore
pathway). Barrier-forming TJ proteins are down-regulated, which further destabilizes the TJ barrier.
Occludin, which is, involved in regulation of permeability for macromolecules, is also down-regulated by
inflammatory processes, leading to increased paracellular permeability for macromolecules (leakpathway). The schematic was drawn using BioRender (https://biorender.com)

1.6 Future Perspectives
Targeted evaluation and therapy understanding new pathways like Notch signaling
mechanisms that manage IBD pathogenesis is crucial to find new therapeutic strategies to
improve patient health. New pathways amendable for therapeutic intervention, can aim to
assist with risk stratification and possible understanding to distinguished response to available
therapies and the development of more personalized medicine. Modulation of individualized
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IBD therapeutic with the purpose of assisting with mucosal healing, recovery of the intestinal
barrier and control aberrant immune responses is the ultimate goal. With a variety of
immunotherapies approaching clinical practice, future studies should consider an individualized
treatment approach based on targeting specific features and components of Notch pathway
from a perspective of downregulating inflammatory response and enhancing mucosal healing.
A humongous unmet need for novel therapeutic approaches exists, since many patients do not
respond to the clinically approved drugs, involving TNF blockers and vedolizumab. Based on
studies in IBD mouse models, evaluation of IBD tissues and new insights into inflammatory
pathways in other chronic inflammatory disorders many new therapeutic approaches have
been developed. Cytokine blockers (such as ustekinumab and JAK inhibitors) suppressing
cytokine signaling are a new addition to IBD therapeutics. Furthermore, identification of
biomarkers to predict and monitor therapeutic success will be crucial to enable individualized
therapy.
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2 NOTCH-1 MEDIATES EPITHELIAL-MUCOSAL HEALING DURING MURINE COLITIS RECOVERY
PHASE
2.1 Introduction
The luminal surface of the colon is continuously exposed to a plethora of foreign
antigens, including food, foodborne pathogens, and commensal bacteria. A single layer of
columnar epithelial cells covers the intestinal mucosa and serves as a barrier to protect the host
from invasion by potential pathogens. Various types of epithelial cells forming a crypt in the
mucosa perform diverse functions. Epithelial stem cells at the crypt bottom continuously divide
to produce transit-amplifying cells, which can then divide several times before creating
terminally differentiated epithelial cell lineages: absorptive enterocytes and three types of
secretory epithelial cells, namely, goblet cells, enteroendocrine cells, and Paneth cells.
Under physiological conditions, the cellular composition of the intestinal epithelium
keeps renewing itself and establishing homeostasis; however, disruption of this homeostatic
state has been associated with various gastrointestinal diseases, including ulcerative colitis (UC)
[18]. Ionizing radiation causes severe damage to healthy tissue. The gastrointestinal tract is a
radiation-sensitive organ, and we used this strategy to induce colitis in mice. Notch-1 proteins
function as receptors for transmembrane ligands, Jagged and Delta-like proteins, to regulate a
broad spectrum of cell fate decisions. Notch-1 receptors undergo γ-secretase–mediated
proteolytic cleavage upon ligand activation to release the Notch intracellular domain (NICD).
The liberated NICD translocate into the nucleus, where it forms a transcriptional activator
complex with other transcriptional factors to regulate the Notch signaling pathway [26].
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However, the involvement of Notch-1 in the pathophysiological changes occurring in
irradiated colonic tissue is still unknown. To better understand the role of Notch-1 signaling in
epithelial defense functions and gut immune homeostasis, we have generated mice in which
there is an intestinal epithelial cell (IEC)-specific deletion of the Notch-1 gene (Notch-1ΔIEC/ ΔIEC)
and exposed them to ionizing (X ray) radiation. Irradiation induced DNA damage in colonic
epithelial cells leading to the loss of tight junctions (Claudin, Occludin, and Zonula occludens
(ZO1), which are essential for epithelial integrity. A leaky epithelium is permeable to all sorts of
pathogens, causing inflammation. Previous studies with transgenic expression indicated that
NICD inhibits secretory cell differentiation with a reciprocal increase in immature progenitors
[26, 27]. These observations support the biological significance of Notch signaling not only in
the binary cell fate decision and in the maintenance of the proliferating progenitors in the
crypts of the intestinal epithelium. So far, the contribution of Notch signaling to epithelial
defense functions remains elusive. It is known that Notch signaling in intestinal epithelium is
upregulated in the inflamed mucosa of UC patients [28]. We are directing toward the crucial
role of Notch in assuring epithelial integrity and rapid turnover of the cells to close the
wound/ulcers created during ablation by inflammation mediated injury.
2.2 Materials and Methods
2.2.1 Animal Models
Mice carrying a floxed Notch-1 allele Notch-1Flox/Flox (using the symbol Notch-1F/F) were
obtained from the Jackson Laboratory. To generate Notch-1ΔIEC/ ΔIEC (using the symbol Notch1ΔIEC) mice, we crossed Notch-1F/F mice with Villin-Cre transgenic mice obtained from The
Jackson Laboratory. Notch-1ΔIEC mice and control Notch-1F/F littermates were maintained under
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specific pathogen-free (SPF) All animal procedures were performed in accordance with the
Guide for the Care of Use of Laboratory Animals. Eight-weeks old, both female and male,
Notch-1F/F (wild type) and Notch-1ΔIEC mice were used. Mice were genotyped by PCR analysis as
previously described. The Notch-l suppression among Notch-1ΔIEC mice was identified by using
PCR genotyping using Notch forward primer (5'-TGCCCTTTCCTTAAAAGTGG-3') and reverse
primer (5'-GCCTACTCCGACACCCAATA-3').
2.2.2 DSS Acute Colitis Induction and Recovery Phase
F/F

ΔIEC

Eight weeks-old, both female and male, Notch-1 and Notch-1

mice were

administered 1.5% Dextran sodium sulfate (DSS) (MP Biomedicals, Solon, OH) through their
drinking water for 5 days to induce acute colitis. Mice were then left to recover on water (no
F/F

DSS added) for 7 days. Mice were euthanized on day 12. Control group mice, Notch-1 and
ΔIEC

Notch-1

, were given regular water for the same amount of time. Body weight and stool

consistency for all the mice were recorded during both, DSS and recovery phase.
2.2.3 Irradiation Injury by X-rays
F/F

ΔIEC

Eight weeks-old, both female and male, Notch-1 and Notch-1

mice were

anesthetized with an intraperitoneal injection of 80 mg/kg ketamine and 10mg/kg xylazine.
Mice whole body irradiation was performed with a single exposure to 2Gy abdominal
irradiation at a dose rate of 1.2 Gy/min using a Rad Source RS 2000 Small Animal Irradiator
(thanks to Zhen Bian-Post doc from Dr Liu’s lab). Intestinal samples were harvested 7 days later
for histologic evaluation. Body weight for all the mice were recorded during before irradiation
and subsequently for a week. On day 7 animals including control mice which were not exposed
to X-rays were sacrificed and their colon was removed.
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2.2.4 Bacterial Culture and Plasmid Preparation
DH5α Competent Cells were mixed with pCMV-IRES2-EGFP plasmids (Epoch Life
sciences) for expressing a gene together with EGFP. Vectors with or without the hNICD1 gene
(2412 bp) between Nhe1 HF and EcoR1 HF restriction sites and transformed through heat
shock. Cells were incubated on ice for 20 minutes, spread on Nutrient broth (BD Biosciences)
agar plates, and cultured in an incubator overnight. Single colonies were moved to liquid broth
and cultured for 8 hours in a shaking incubator. 200µl of the broth was moved to 500ml liquid
broth (Sigma Aldrich) culture flasks and incubated overnight in a shaking incubator. Cells were
isolated by centrifuging cultured broth, and plasmids were prepared using (Invitrogen,
PureLink™ HiPure Plasmid Midiprep Kit), following the manufacturer's protocol. The obtained
plasmid DNA was resolved in nuclease/endotoxin-free water and stored at −20℃.
2.2.5 Cell Culture, Transfection, Wound Healing Assay, and Migration Assay
HCT116 cells, colon human carcinoma cells, were cultured McCoy's 5a Medium Modified
(ATCC, catalog No. 30-2007) supplemented with 10% FBS (Atlanta Biologicals), and 100 units/ml
penicillin, and 100 mg/ml streptomycin (GIBCO) at 37°C in 5% CO2. Cells (5 x 105) were seeded
in 6 well plates and incubated for 24 hrs. When cells were 70-90% confluent, cells were then
transfected with hNICD1 cloned into pCMV-IRES2-EGFP vector or without hNICD1 (Empty
vector) pCMV-IRES2-EGFP. The plasmids were transiently transfected into HCT116 cell line using
Lipofectamine 3000 transfection kit (Invitrogen) according to the manufacturer's protocol. 24 h
after transfection, monolayer was wounded by scratching method with a sterile pipette tip and
images were taken at 24, and 48 hr by using Keyence BZ-X700 microscope. Transfection
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efficiency was done by looking at the change in enhanced green fluorescent protein (EGFP)
signals in fluorescence microscope.
For migration- 24 hr after transfection, cells were treated with mitomycin C (10 µg/ml)
for 3 hours and washed 3 times with PBS to inhibit cell proliferation. Scratch assay was
performed to assess cell migration. The pictures were taken at time points 0, 24, or 48
observing the width of the cell free gap closing. Experiments were performed in duplicate and
on at least on two separate occasions. Cell migration was assessed by measuring the remaining
open area of the wound by ImageJ software.
2.2.6 Protein Extraction and Western Blot (WB) Analysis
Colonic epithelial mucosal stripping was obtained from whole colon of Notch-1F/F (wild
type) and Notch-1ΔIEC (conditional knockout) mice with and without exposure to X ray
irradaition. Protein for WB was extracted from the stripping using Pierce RIPA buffer (Cat#
89900, Thermo Fisher Scientific) mixed with Halt Protease & Phosphatase Inhibitor Cocktail
(100×, Cat# 78440, Thermo Fisher Scientific). Samples were quantified using the DC protein
assay (Bio-Rad). Quantified samples were prepared with LDS sample buffer with or without βmercaptoethanol (Sigma-Aldrich) for nonreducing gels. Prepared samples were boiled at 58℃
for 10 minutes and briefly centrifuged. 10% Criterion™ TGX™ Precast Midi Protein Gel, 18 well
were loaded with protein samples, β-tubulin (Sigma-Aldrich) and GAPDH (Abcam)was used as
loading control. Followed by electrophoresis in Tris-glycine SDS buffer. Proteins were
transferred to nitrocellulose membranes that were then blocked with TBS-T supplemented with
5% skimmed milk or 5% filtered-BSA. Primary antibodies ATOH1 (BD Biosciences), Hes-1
(Affinity Bioreagents), Claudin 2 (Invitrogen), Claudin 1 (Invitrogen), NF-kB (Invitrogen),
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Occludin (Invitrogen), GAPDH (cell Signaling), ZO1 (Cell Signaling) were diluted in 5% skimmed
milk or 5% filtered-BSA and incubated overnight at 4°C with rocking. Membranes were washed
and incubated with horseradish peroxidase (HRP)-conjugated secondary antibodies (goat antimouse secondary antibody (Bio-Rad) or goat anti-rabbit secondary antibody (Abcam)) diluted in
5% skimmed milk for 3 hours. Chemiluminescence was optimized by ECL (Super signal West
Pico Plus, Thermo Fisher Scientific), and signals were pictured using BIO-RAD CHEMIDOC touch
imaging system.
2.2.7 Mouse Colonoscopy
Notch-1F/F and Notch-1ΔIEC mice with and without radiation exposure were subjected to
colonoscopy to assess the mucosal layer thickness, signs of inflammation, and dysplastic
lesions. This was performed using the colonoscope (Xenon Nova 47S, STORZ).
2.2.8 Hematoxylin and Eosin (H&E) Staining and Histological Score Evaluation
Formalin fixed and paraffin embedded colon Swiss rolls from Notch-1F/F and Notch-1ΔIEC
mice with and without radiation exposure were stained with H&E. Histological scores were
evaluated based on inflammation infiltration of white blood cells, crypt damage, and foci of
ulceration in the entire colon. Images were taken using Keyence BZ-X700 microscope at X10,
X20 and X40 magnification.
2.2.9 Alcian Blue-Periodic Acid Schiff (AB-PAS) Staining
Formalin fixed and paraffin embedded colon Swiss rolls from Notch-1F/F and Notch-1ΔIEC
mice with and without radiation were used. Sections were deparaffinized, hydrated and
incubated with acetic acid for 3min. Sections were stained with 3% Alcian Blue (Sigma-Aldrich).
Next, sections were stained with periodic Acid Solution for 5 minutes at room temperature (18–
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26°C). After washing, sections were incubated with Schiff’s Reagent for 15 minutes at room
temperature (18–26°C). Rinsed the slides again and counterstain slides in Hematoxylin Solution,
Gill No. 3, for 90 seconds. The slides were washed, and sections were then hydrated with
alcohol, cleared with xylene, and sealed. Images were taken using Keyence BZ-X700 microscope
at X20 magnification.
2.2.10 RNA Extraction and QPCR Analysis
Total RNA was extracted from colonic tissues using the RNeasy mini-Kit (Qiagen)
according to the manufacturer's instructions. Then, complementary DNA was generated from
the total RNA isolated using the Maxima first-strand complementary DNA synthesis kit (Thermo
Scientific). The cDNA samples were amplified with the DreamTaq Green PCR Master Mix (2X)
(Thermo Scientific) and the primer sets specific for mouse genes. The sequences of the primer
sets are shown in the table. Target gene expression was assessed by a comparative cycling
threshold method, using expression of 36BR gene levels as the internal standard. Realtime
QPCR data is depicted as fold change (DDCT values). Bacterial genomic DNA was isolated by
gently scraping the inside of the colon. Bacterial genomic DNA samples were amplified with a
Eppendorf (Realplex 4 Mastercycler epgradient S 5345 Real Time PCR 96 Well) using the
DreamTaq Green PCR Master Mix (2X) and the primer sets specific for bacterial 16S rDNA.

NOTCH-1 MEDIATES EPITHELIAL-MUCOSAL HEALING
Primers
Notch-1
JAG-1
JAG-2
DLL-1
DLL-3
DLL-4
IL-6
IFN-γ
IL-22
IL-17
TNFα
IL-12
IL-10
IL-1β
MUC2
Reg3α
Reg3β
Reg3γ
36BR
16S
Firmicutes sp.
Bacteroidetes sp.
Fusobacterium sp.
Akkermensia muciniphila

5' forward 3'
TGCCCTTTCCTTAAAAGTGG
GAGGCGTCCTCTGAAAAACA
TCCTCCTGCTGCTTTGTGAT
ACAGAGGGGAGAAGATGTGC
TCGTACGTGTGCCCTTCC
AGGTGCCACTTCGGTTACAC
GTGGCAGGTAGAGCAGGAAG
GTCTCTTCTTGGATATCTGGAGGAACT
GTGCTCAACTTCACCCTGGA
TGAGCTTCCCAGATCACAGA
AGGCTGCCCCGACTACGT
GCCAGTACACCTGCCACAAA
CCCGTCCTTAAAGCTGTCTG
GGTCAAAGGTTTGGAAGCAG
ATGCCCACCTCCTCAAAGAC
GGCACCGAGCCCAATG
ATACCCTCCGCACGCATTAGTT
TTCTTGTCCTCCATGATCAAAA
TCCAGGCTTTGGGCATCA
AGAGTTTGATCCTGGCTCAG
GGCAGCAGTRGGGAATCTTC
GGARCATGTGGTTTAATTCGATGAT
CAACCATTACTTTAACTCTACCATGTTCA
CAGCACGTGAAGGTGGGGAC

17
5' reverse 3'
GCCTACTCCGACACCCAATA
ACCCAAGCCACTGTTAAGACA
TGTCAGGCAGGTCCCTTG
CCCTGGCAGACAGATTGG
TGCTCTCTCCAGGTTTCAATG
GGGAGAGCAAATGGCTGATA
CCACCTGAAAGGCACTCTGT
GTAGTAATCAGGTGTGATTCAATGACGC
TGGATGTTCTGGTCGTCACC
TCCAGAAGGCCCTCAGACTA
GACTTTCTCCTGGTATGAGATAGCAAA
TGTGGAGCAGCAGCAGATGTGAGT
AATTGGAATCCAGGGGAAAC
TGTGAAATGCCACCTTTTGA
GTAGTTTCCGTTGGAACAGTGAA
GGATTTCTCTCCCATGCAAAGT
AGGCCAGTTCTGCATCAAACCA
CATCCACCTCTGTTGGGTTCA
CTTTATCAGCTGCACATCACTCAGA
CTGCTGCCTCCCGTAGGAGT
ACACTTAGTACTCATCGTT
AGCTGACGACAACCATGCAG
GTTGACTTTACAGAAGGAGATTATGTAAAAATC
CCTTGCGGTTGGCTTCAGAT

Table 1. Sequences of the QPCR primers used in the study.

2.2.11 Immunofluorescence Staining of Colon Swiss Rolls
Notch-1F/F and Notch-1ΔIEC mice with and without radiation colon Swiss rolls were
formalin fixed and paraffin embedded for immunofluorescence staining. 5-μm-thick paraffinembedded sections of colon tissue samples were deparaffinized by xylene and dehydrated by
different concentration of alcohol solutions and then were treated with citrate buffer (pH 6.0)
for antigen retrieval. Immunostaining was performed according to manufacturer’s protocol
using the Tyramide SuperBoost™ Kits with Alexa Fluor™ Tyramides (Invitrogen). 3 % H2O2 was
used to block endogenous peroxidase for 15 min, followed by diluted goat serum to reduce
nonspecific staining for 30 min. After that, the sections were incubated with primary Ki67
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(1:200, ab16667, Abcam), MUC2 (GeneTex), Lgr5 (Santa Cruz Biotechnology), ZO-1 (Cell
signaling), Cyclin D1( A-12, Santa Cruz Biotechnology), Lysozyme C (E-5, Santa Cruz
Biotechnology) at 4 °C overnight. Washed the slides three times with PBS and added 2–3 drops
(approximately 100–150 µL) of anti-mouse/anti rabbit poly-HRP-conjugated secondary antibody
to the tissue and incubate for 60 minutes at room temperature. Rinsed the section for 10
minutes with PBS at room temperature. Applied 100 μL of the Alexa Fluor™ 594/488 Tyramide
reagent and incubated for 2–10 minutes at room temperature. Reaction was ceased using stop
reagent. Counterstain the section with Phalloidin iFluor 488/555 diluted with 1X PBS for 1 h.
Finally, the sections are mounted with ProLong Gold antifade reagent with DAPI (Invitrogen)
with coverslip. Images were taken with Keyence BZ-X700 microscope.
2.2.12 Apoptotic Cell Labeling via TUNEL Staining
Paraffin sections of colons were deparaffinized and apoptotic cells were identified by
immunofluorescent terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate
nick-end labeling (TUNEL) staining using In Situ Cell Death Detection Kit, Fluorescein (MilliporeSigma) according to the manufacturer's instructions. Quantification of apoptosis was performed
by counting the number of apoptotic cells in a crypt and was shown as percentage values.
2.2.13 Statistical Analysis
Differences between two groups were analyzed by Student t test. When variances were
not homogeneous, the data were analyzed by Mann Whitney U test. Differences among more
than two groups were analyzed by one-way ANOVA followed by Dunnett test. When variances
were not homogeneous, the data were analyzed by Kruskal–Wallis test. All data was expressed
as means± SEM. P values <0.05 was considered statistically significant [ ns = non-significant, **
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= p<0.01, *** = p<0.001, **** = p<0.0001]. Statistical tests were applied using GraphPad Prism
(version 6).
2.3 Results
2.3.1 Conditional Deletion of Notch-1 in Colonic Epithelium Compromises the
Architecture and Cell Differentiation in the Colon

Figure 6. Conditional deletion on Notch-1 signaling in mice colon leads to the loss of epithelial crypt
architecture and increased goblet cell population.
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Notch-1ΔIEC mice were generated using the breeding scheme for generating Cre/lox tissue-specific
knockouts by The Jackson Laboratory Cre/lox system. Notch-1F/F mice were used as a control. (A)
Qualitative PCR of the DNA extracted from mice tails with the primers designed by the supplier (Jackson
Laboratories). Homozygous Notch-1ΔIEC mice have one mutant band at 281 bp, while heterozygous mice
have two bands, the mutant at 281 and the Notch-1F/F at 231 bp. Lane 3 is a 100 bp ladder. Each lane
shows blots performed loading (25μg/lane) using whole organ cell lysate of the colon from Notch-1ΔIEC
and Notch-1F/F groups. (B) Expression of NICD-1 in different organs in homeostasis is probed using an
anti-NICD antibody, and GAPDH was used as a loading control. (C) Colonic tissue sections were stained
with H&E for histological examination in the presence and absence of Notch-1. (D) The histological
colitis score was calculated based on the criteria described in the materials and methods section. Scale
bars, 100 μm. Data are representative of three independent experiments. (E) AB-PAS staining for
detection of goblet cells (lower panels). (F) The number of goblet cells per crypt was quantified. Values
are mean ± SD (n = 5). **p < 0.01 (Mann–Whitney U test).

To directly assess the role of epithelial Notch signaling in intestinal homeostasis, we
generated Notch-1ΔIEC mice. These mice were born at the expected Mendelian ratio. The Notch
l deletion among Notch-1ΔIEC mice was identified by using PCR genotyping. (Fig 6A) shows the
genotyping result where lanes 1 and 2 are homozygous Notch-1ΔIEC mice expressing only one
band (281 bp) while lanes 4 and 5 are heterozygous mice, expressing two bands, the mutant
and the Notch-1F/F (281 and 231 bp, respectively). (Fig 6B) To confirm Notch-1 presence at the
protein level, protein lysates were prepared from Notch-1F/F mice vital organs such as the colon,
small intestine, liver, kidney, lung, and stomach. All the organs respectively indicate the
presence of Notch-1, depicting that Notch-1 is essential in all organs to maintain homeostasis.
Histological analysis of Notch-1ΔIEC mice showed a massive cellular infiltration, disrupted crypt
architecture, increased neutrophil infiltration, and a few foci of ulceration compared to Notch1F/F mice (Fig 6C and 6D). The histological score is calculated using three parameters described
in the methods section. The bar graph shows that Notch-1ΔIEC mice had a significantly higher
histological score (5.5 ± 0.5) compared to Notch-1F/F mice (1.5 ± 0.5). Notch-1 mediates the
enterocyte population against goblet cells and mucus secretory cells during stem cell
differentiation in the colon. AB-PAS staining of these 8-wk-old Notch-1ΔIEC mice demonstrated
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that the number of secretory cell lineages was increased in the colon (Fig. 6E), an observation
consistent with a previous observation in mice with inducible Notch-1 deficiency [29]. The acidic
mucins are identified by Alcian blue and neutral mucins by PAS; wherever crypt mixtures occur,
the resultant color will depend upon the dominant moiety. Notch signaling drives early crypt
progenitors to control their lineage determination. Phenotypic alterations occurred mainly in
the crypts and were homogeneous throughout the intestinal and colonic mucosa in Notch-1F/F
mice (Fig. 6E), demonstrating highly efficient excision of the Notch-1-floxed alleles by the Cre
transgene and the absence of a mosaic phenotype. Goblet cell hyperplasia was particularly
obvious in the colon of Notch-1ΔIEC mice. AB-PAS images indicated that Notch-1ΔIEC had more
goblet cells compared to Notch-1F/F mice. (Fig 6F) is the bar graph representation of the goblet
cell hyperplasia due to the conditional deletion of Notch-1 signaling. It shows quantification of
goblet cells, indicating that Notch-1ΔIEC mice had a significantly increased no. of goblet cells
(22.3 ± 0.3) compared to Notch-1F/F mice (6.2 ± 0.7). This data indicates that Notch-1ΔIEC mice
have a defect not only in the regulation of IEC differentiation but also in the maintenance of gut
homeostasis.

NOTCH-1 MEDIATES EPITHELIAL-MUCOSAL HEALING

22

2.3.2 Notch-1 Signaling Mediates Inflammation in DSS-Induced Acute Colitis

Figure 7. Notch-1 signaling mediates inflammation in DSS-acute colitis mice.
DSS induced damage in the colon of Notch-1F/F and Notch-1ΔIEC mice (A) The schematic of DSS model of
inducing colitis in Notch-1F/F and Notch-1ΔIEC mice (n=5/group) and recovery for seven days. (B) Changes
in body weight were monitored throughout the experiment, and mice were euthanized on day 12. (C)
HE staining of colon swiss rolls from Notch-1F/F and Notch-1ΔIEC mice given 1.5% DSS in water. Scale bars
are 100µm (D) Histology score based on HE staining method. Data were expressed as mean ± SD
(Student t-test). * p < 0.05, ** p < 0.01 vs. 1.5% DSS groups (Notch-1F/F and Notch-1ΔIEC). (E) Colonoscopy
images to show inflammation in colon increased slightly in Notch-1F/F mice after DSS induced colitis but
Notch-1ΔIEC mice had escalated inflammatory response. Scale bars, 100 μm.
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Eight weeks old, both female and male, Notch-1F/F and Notch-1ΔIEC mice were given 1.5%
DSS to induce acute colitis. Body weight of mice was monitored throughout the experiment and
mice were euthanized at day 12. (Fig. 7A) shows the schematic of DSS acute colitis recovery
model. (Fig. 7B) Shows the bodyweight change in percentage indicating a significant increase in
body weight among Notch-1F/F mice compared to Notch-1ΔIEC mice during the recovery period.
(Fig. 7C) To assess inflammation among Notch-1F/F and Notch-1ΔIEC mice in acute colitis, H&E
staining was performed. H&E images indicate crypt architecture damage, infiltration of
neutrophils, and loci of ulceration among Notch-1ΔIEC mice compared to Notch-1F/F mice in
acute colitis. (Fig. 7D) Bar graph representation of histological score calculated on three
parameters: infiltration of neutrophils, loss of crypt structure, and foci of ulceration. (Fig. 7E)
shows colonoscopy images indicating the thinning of mucosa and bleeding among Notch-1ΔIEC
mice compared to Notch-1F/F mice. This data confirms that Notch-1ΔIEC mice are taking longer to
recover from DSS induced colitis in comparison to Notch-1F/F mice. This observation might
suggest that Notch-1 is essential for faster healing.

NOTCH-1 MEDIATES EPITHELIAL-MUCOSAL HEALING

24

2.3.3 Notch-1 Affects Production of Proinflammatory Cytokines in DSS Colitis in Mice

Figure 8. Notch-1 affects production of proinflammatory cytokines in DSS colitis in mice.
(A) mRNA expression of cytokines including TNF, IL-6, IL-12, IL-1β and IFNγ was examined by qRT-PCR in
colonic mucosa from 8-week-old mice after 12-day recovery from DSS acute colitis. Data is depicted as
fold change. Data were normalized to expression of 36BR (housekeeping gene). Data were expressed as
mean ± SD (n=5) of three independent experiments. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p <
0.0001, vs. radiation groups (one-way ANOVA test followed by Dunnett test).
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To assess the inflammatory environment, mRNA levels of cytokines that are known to
mediate acute inflammatory progression in experimental colitis were measured by qPCR as
described in the methods section. Interestingly, the mRNA levels of all pro-inflammatory
cytokines were higher in Notch-1ΔIEC mice as compared to Notch-1F/F mice (Fig.8A). These
results together with the inflammation observed via

H and E staining and colonoscopy

indicate that Notch-1 signaling mediates DSS-induced colitis and is associated with upregulation
of pro-inflammatory.
2.3.4 Deletion of Notch-1 in IECs Induces Significant Epithelial Damage During Colitis

Figure 9. Notch-1 relieves radiation-induced colitis in mice.
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Radiation-induced damage in the colon of Notch-1F/F and Notch-1ΔIEC mice (A) The schematic of radiation
model inducing colitis in Notch-1F/F and Notch-1ΔIEC mice (n=5/group) and recovery for seven days. (B)
Changes in body weight were monitored throughout the experiment, and mice were euthanized on day
7. (C) Western blot comparing Notch-1 expression in radiated mice (Notch-1F/F and Notch-1ΔIEC) vs.
control. (D) H&E staining of colon swiss rolls from Notch-1F/F and Notch-1ΔIEC mice exposed to radiation
(magnification X10, X20, and X40). Scale bars are 100µm (E) Histology score based on H&E staining
method. (F) Statistics of colon length. Data were expressed as mean ± SD (Student t-test). * p < 0.05, **
p < 0.01 vs. radiation groups (Notch-1F/F and Notch-1ΔIEC).
F/F

ΔIEC

Eight weeks old, female and male, Notch-1 and Notch-1

mice, were irradiated with a

single exposure to 2Gy abdominal irradiation at a dose rate of 1.2 Gy/min small animal
irradiator (Fig. 9A). Intestinal samples were harvested seven days later for histologic evaluation.
Body weight for all the mice was recorded before irradiation and subsequently for a week. (Fig.
9B) During the experiment, the body weight of animals in the Notch-1ΔIEC irradiated group
continued to decrease significantly from day 3. Compared with the Notch-1F/F group, body
weight loss dramatically improved due to the lack of the Notch-1 gene. (p < 0.01). (Fig. 9C) In
addition, a western blot was run to check the protein levels of Notch-1 in different groups,
clearly depicting increased Notch-1 levels in Notch-1F/F as compared to Notch-1ΔIEC, which
doesn't have the gene, but Notch-1F/F Notch-1 levels increased in colitis over Notch-1F/F control
mice never treated with radiation [30]. In line with the above findings, epithelial crypt damage,
mucosa edema, depletion of goblet cells, and inflammatory cell infiltration was observed in HE
F/F

ΔIEC

staining of the , Notch-1 and Notch-1
1

ΔIEC

mice, but more damage is observed in Notch-

F/F

mice as compared to , Notch-1 mice (Fig. 9D).
Furthermore, the histology score, assessing the severity of colitis, increased distinctly

after radiation treatment, whereas it was markedly lower in the Notch-1ΔIEC as compared to the
Notch-1F/F group. Nevertheless, the Notch-1F/F group exhibited obvious protection from mucosa
damage and less histological inflammation, which showed a lower histopathological score (Fig.
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9E). Although there were clinical manifestations of bloody diarrhea and body weight reduction,
the colon length was unchanged in Notch-1F/F and Notch-1ΔIEC groups before and after radiation
(Fig. 9F). Combined, these results demonstrate that Notch-1 exerts therapeutic effects on
radiation-induced colitis.
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2.3.5 Notch-1 Ameliorates Radiation-Induced Epithelial Permeability by Enhancing the
Function of Tight Junctions

Figure 10.Notch-1 ameliorates radiation-induced epithelial permeability by enhancing the function of
tight junctions.
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(A) and (B) Immunoblotting for claudin 2, claudin 1, occludin, and ZO-1 in membrane protein extracts
obtained from the colon of radiation-induced colitis mice groups (Notch-1ΔIEC and Notch-1F/F). (C)
Expression of inflammatory mediators in colitis in Notch-1ΔIEC and Notch-1F/F mice. (D) qRT-PCR was used
to examine the mRNA expression of TNF-α, IL-1β, and IFN-γ. Data were expressed as mean ± SD of three
independent experiments. (0ne-way ANOVA) * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, vs.
radiation groups (Notch-1ΔIEC and Notch-1F/F). (E) Immunofluorescence staining for Claudin-2 TJ in the
distal colon of 8 wk-old Notch-1ΔIEC mice and control Notch-1F/F (2Gy and water group) using mAbs
against Cld-2 (green), nuclei were counterstained with DAPI (blue). Scale bars, 100 μm. (F)Quantification
of Claudin 2 expression/cell in 2Gy condition in Notch-1ΔIEC and Notch-1F/F mice. Data are representative
of three independent experiments. Values are mean ± SD (n = 5). *p < 0.05 (Student t-test).

Depending on the nature and the site of the inflammation, occludin, ZO-1, and different
claudin proteins have been implicated in the pathogenesis of IBD [20]. Increased expression of
claudin-1, -2, and -18 [31-35] and downregulation of claudin-3, -4, and -7 were reported in
ulcerative colitis [32, 33]. Replacement of barrier-forming claudins with pore/channel-forming
claudins like claudin-2 influences ion and fluid movement across cells, which is reflected in
disease symptoms, including diarrhea. Analysis of many tight junctions in the presence or
absence of Notch-1 in colitis showed that the lack of a Notch-1 in Notch-1ΔIEC mice dramatically
increased claudin-2 expression. Conversely, occludin expression was markedly decreased. The
effect on claudin-1 was relatively mild, although it was also reduced (Fig. 10B). ZO connects
junctional proteins such as occludin and claudin to the actin cytoskeleton, and these protein
interactions maintain TJ formation and function. There was a marked reduction in ZO-1
expression in Notch-1ΔIEC mice exposed to radiation colitis (Fig. 10A). To define the mechanism
that associates Notch-1 signaling and barrier function and inflammatory mediators influence on
transcriptional regulation of claudins in the TJ, we performed western blotting of NF-κB and
STAT3 (Fig. 10C). Pro-inflammatory cytokines such as TNF-α, IL-1β, and IFNγ promote TJ
permeability. TNF-α suppresses TJ barrier function due to the activation of the NF-κB pathway
and decreased ZO-1 protein level. IL-1β increased TJ permeability via activation of the NF-κB
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pathway[36]. (Fig. 10D) To test the role of cytokines in inflammation and how they affect
different TJ proteins, the levels of TNF-α, IL-1β, and IFNγ were checked via QPCR. These data
were correlated by immunofluorescence staining (Fig. 10E). We confirmed that claudin-2 was
localized to the cell junction and was upregulated when Notch-1 was knocked out. In the
physiologic state, claudin-2 expression is restricted to proliferative colonic crypt base epithelial
cells. During mucosal inflammation, claudin-2 expression is upregulated in cells, and its
expression extends beyond the crypt-base proliferative cells in the colon[37]. Moreover, this is
depicted in the immunofluorescence images crypt to upper compartment movement of
claudin-2. Therefore, the absence of Notch-1 mediated disruption of this stoichiometry may
account for the abnormal barrier function. Altogether, these findings provide evidence for the
involvement of the Notch-1 signaling pathway not only in barrier function but also in the
architecture of the epithelium.
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2.3.6 Notch-1 Inhibits Apoptosis and Promotes Proliferation in the Colonic Epithelium
in Mice with Radiation-Induced Colitis
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Figure 11. Notch-1ΔIEC mice have a reduction in apoptotic cells and increment in proliferating
epithelial progenitors in the colon.
(A) Immunofluorescence staining of the distal colon from Notch-1ΔIEC mice and control Notch-1F/F
littermates was performed using polyclonal Ab against Ki67. The number of Ki67+ proliferating cells per
crypts was quantified. Values are mean ± SD (n = 5). **p < 0.01 (Mann–Whitney U test). Scale bars, 100
μm. (B) Immunoblotting of the distal colon from radiated Notch-1ΔIEC mice and control Notch-1F/F
littermates was performed using Ab against Hes1. Data are representative of three independent
experiments. (C) Immunofluorescence staining of the distal colon from Notch-1ΔIEC mice and control
Notch-1F/F littermates was performed using Ab against Cyclin D1. (D) Epithelial cell apoptosis in Notch1ΔIEC mice and Notch-1F/F mice. TUNEL assay (In Situ Cell Death Detection Kit) was used to visualize
apoptotic cells with fluorescein-dUTP (green), followed by DAPI for nuclei counterstaining (blue). Scale
bars, 100 μm. (E) For quantification analysis, 20 crypts per mouse were randomly selected, and the
number of green cells per crypt was counted. ***p < 0.001 (Mann–Whitney U test).

The disruption of homeostasis between proliferation and apoptosis in the colonic crypts
is engaged in the pathogenesis of UC[38-40]. So, the proliferation and apoptosis of colon
epithelial cells were examined by immunostaining of Ki67 to test cell proliferation and
apoptosis by TUNEL assay. Ki67+ proliferating cells were abundant at the bottom of virtually all
the crypts in control mice, whereas Ki67+ cells were nearly absent in multiple crypts of Notch1ΔIEC mice (conditions- water or radiation-induced colitis) (Fig. 11A). Notch-mediated Hes1
expression contributes to the cell proliferation in the intestinal crypts by transcriptional
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repression of the Cyclin D1 regulator [41]. Immunostaining analysis detected Cyclin D1+ cells in
the bottom of every crypt in control mice; however, such cells were nearly absent in the crypts
of Notch-1ΔIEC mice (Fig. 11B). Western blot of Hes1 protein suggests that reduction in epithelial
cell proliferation may result from the downregulation of Hes1 because of the absence of Notch1 (Fig. 11C). These data also raise the possibility that Notch-1ΔIEC mice are defective in epithelial
cell turnover and activate apoptosis. We, therefore, performed TUNEL assay (Fig. 11D). The
hallmark of apoptosis is DNA degradation. The DNA cleavage may yield DNA breaks (nicks)
which can be detected by TUNEL (TdT-mediated dUTP-X nick end labeling). (Fig 11E) To quantify
the rate of colonic epithelial apoptosis, we counted the number of apoptotic cells per crypt.
Consistent with Ki67-staining data, the number of apoptotic cells was significantly increased in
the colonic epithelium of Notch-1ΔIEC. Overall, these results suggest that Notch-1 helps maintain
the intestinal epithelium barrier by preventing apoptosis and enhancing proliferation.
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2.3.7 Notch Enhances Intestinal Barrier Function and Epithelial Cell Differentiation of
Radiation-Induced Colitis Mice
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Figure 12. Notch-1 modulates the expression of antimicrobial proteins and inhibits secretory cell
lineage differentiation in colonic epithelium.
(A) Immunofluorescence staining for MUC2 in the colon of 8 week-old Notch-1ΔIEC mice and control
Notch-1F/F (2Gy and water group) using mAbs against MUC2 (red), nuclei were counterstained with DAPI
(blue). Scale bars, 100 μm. (B) AB-PAS staining for detection of goblet cells. The number of goblet cells
per crypt was quantified. Values are mean ± SD (n = 5). ***p < 0.01 (Mann–Whitney U test). (C)
Immunoblotting for Hes-1 and ATOH1 in membrane protein extracts obtained from the colon of
radiation-induced colitis mice groups (Notch-1ΔIEC and Notch-1F/F). (D) Immunofluorescence staining for
Lysozyme C in the colon of 8-week-old Notch-1ΔIEC mice and control Notch-1F/F (2Gy and water group)
using mAbs against Lysozyme C (red), nuclei were counterstained with DAPI (blue). Scale bars, 100 μm.
(E) qRT-PCR was used to examine the mRNA expression of Reg3α, Reg3β, and Reg3γ. Data were
expressed as mean ± SD of three independent experiments. (0ne-way ANOVA) * p < 0.05, ** p < 0.01,
*** p < 0.001, **** p < 0.0001, vs. radiation groups (Notch-1ΔIEC and Notch-1F/F). (F)
Immunofluorescence staining for Lgr5+ in the colon of 8 wk-old Notch-1ΔIEC mice and control Notch-1F/F
(2Gy and water group) using mAbs against Lgr5+ (red), nuclei were counterstained with DAPI (blue).
Scale bars, 100 μm.
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Mucus secreted from the crypt mixes with Paneth cell secretions containing
antibacterial peptides, lysozyme, DMBT1, and MUC2 [42-46]. The Paneth cell products will,
together with enterocyte-produced antibacterial proteins like Reg3γ, generate an antibacterial
gradient in the mucus and keep the bacteria away from the epithelial cell surfaces. Notch
signaling in the colon is implicated in the maintenance of stem cells and progenitor cells and the
inhibition of goblet cell differentiation. In the intestine, Notch signaling, especially Notch1,
regulates stem cell-fate determination in the crypt [47]. Once stimulated, activation of Notch
upon ligand binding promotes the expression of Hes-1 (Hairy and Enhancer-of-split-1), which
then would suppress downstream ATOH1, resulting in an increase of enterocytes in parallel
with restricting differentiation into goblet cells and MUC2 expression (Fig. 12A). Enhanced
levels of MUC2 are observed in Notch-1 conditional knockouts. [19, 48, 49]. Moreover, Notch1ΔIEC mice exhibited goblet cell hypertrophy and hyperplasia as identified by Alcian Blue (Fig.
12B)
Notch-1 deletion activated secretory cell lineage differentiation. Western blotting data
shows that Notch-1 mediates Hes-1 and inhibits ATOH1 expression and hence suppresses
goblet cell proliferation (Fig.12C). Enhanced expression of lysozyme showed that the Paneth
cell population was expanded in Notch-1ΔIEC mice as compared to Notch-1F/F mice after
radiation-induced colitis[50] (Fig. 12D). Immunostaining of lysozyme identified Paneth-like cells
in the colonic epithelium of Notch-1ΔIEC and Notch-1F/F mice[51]. We subsequently examined
the expression of antimicrobial proteins in the colonic epithelium (Fig. 12E). The expression of
the regenerating islet-derived (Reg) gene family encoding Reg3α, Reg3β, and Reg3γ in the
colonic epithelium of Notch-1ΔIEC and Notch-1F/F mice in different conditions. Interestingly, The
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expression of antimicrobial proteins Reg3α, Reg3β, and Reg3γ, all of which are known to be
secreted by Paneth cells [52, 53], was remarkably upregulated in the colonic epithelium of
Notch-1ΔIEC mice without any significant difference from Notch-1F/F mice after radiation insult.
Collectively, ablation of Notch-1F/F unlikely attenuates the production of antimicrobial proteins
by IECs. Radiation depletes Lgr5+ cells [54] [55]. Notch-1 overexpression in the crypt after
ablation of Lgr5+ regenerates stem cells [55]. (Fig. 12F) Lgr5+ cells were seriously
downregulated after radiation exposure in Notch-1ΔIEC mice. However, some regeneration was
seen in Notch-1F/F mice even after the insult. This shows that Notch-1 mediates regeneration
and proliferation in the colon crypt.
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2.3.8 Notch-1 is Essential for Injury-Induced Intestinal Stem Cell Recovery Through its
Ligands-Controlled Expression Under the Switch of the KLF5 Modulator

Figure 13. Role of Notch-1 in injury-induced healing.
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(A) Colonic tissue sections of 8 wk-old Notch-1ΔIEC mice and control Notch-1F/F (2Gy and water group)
were stained with anti-KLF5 antibody (red), nuclei were counterstained with DAPI (blue). Scale bars, 100
μm. (B) Expression of Notch ligands in the intestinal epithelium of Notch-1ΔIEC and Notch-1F/F littermates,
RT-qPCR was used to examine the mRNA expression of DLL-1, DLL-3, and DLL-4 (C) The expression of
more Notch ligands JAG-1 and JAG-2 were analyzed by RT-qPCR in colonic epithelial mucosa. Data were
normalized to the expression of 36BR. Data were expressed as mean ± SD of three independent
experiments (n=5) * p < 0.05, ** p < 0.01, *** p < 0.001 (one-way ANOVA).

Intestinal Stem Cells (ISCs) replenish the epithelium daily. However, radiation-induced
colitis ablates Lgr5 ISCs. In return, this was found to activate stemness's function in slow-cycling
progenitors or even differentiated epithelial cells, most notably secretory lineages [56]. Notch
signaling pathway is required for ISCs to maintain stemness. KLF5 is an epithelial cell-intrinsic
regulator essential for epithelial regeneration after injury-induced ISC attrition. Klf5
deacetylation activates NOTCH signaling, Hes1, Jagged 1, and DLL-1, which promotes luminal
cell proliferation [57, 58]. To investigate if Notch-1 affects KLF5 directly, we performed
immunostaining using KLF5 specific antibody in Notch-1ΔIEC, and Notch-1F/F colon mucosal
epithelial cells in radiation caused colitis condition vs. normal no radiation (Fig. 13A). Notch-1F/F
mice significantly lost KLF5 expression post-radiation. However, the ligand responsible for such
an increase in Notch activation remains uncertain. Therefore, we examined the expression of
DLL-1, DLL-3, DLL-4, JAG-1, and JAG-2 in colitic mucosal tissues of radiation-colitis mice. (Fig.
13B) RT-qPCR analysis showed a surprising loss of Dll1 expression in Notch-1F/F radiation-colitis
mice. Conversely, a striking increase in the mRNA expression of Dll4 was observed in Notch-1F/F
2Gy, suggesting that a distinct regulation of Dll1 and Dll4 expression exists under the
inflammatory environment. (Fig. 13C) DLL-3 and JAG-2 didn't show any significant difference
from the control, but JAG-1 expression was reduced in Notch-1F/F and Notch-1ΔIEC mice postradiation. Dll4 and JAG-1 may act as a significant Notch ligand in the crypts of the inflamed
colonic mucosa. It supported the conclusion that Notch-1 lowers the expression of KLF5 and
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hence mucus producing cells known to proliferate in the presence of KLF5. Notch-1 doesn't let
the cells differentiate in the transit-amplifying region; rather dedifferentiates them for ISC
renewal. As the secretory cells decrease during colitis, DLL-1 primary ligand expressed by goblet
cells also decreases.
2.3.9 Notch-1 Regulates Mucosal Inflammation Through Interaction with Cytokines

Figure 14.Notch-1 affects pro-inflammatory and anti-inflammatory cytokines production in mice with
radiation-induced colitis.
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(A) mRNA expression of cytokines including TNF, IL-6, IL-12, IL-22, and IL-10 was examined by qRT-PCR in
colonic mucosa from 8-week-old mice after seven days of recovery from radiation injury. Data is
depicted as fold change. Data were normalized to the expression of 36BR (housekeeping gene). Data
were expressed as mean ± SD (n=5) of three independent experiments. * p < 0.05, ** p < 0.01, *** p <
0.001, **** p < 0.0001, vs. radiation groups (one-way ANOVA test followed by Dunnett test). (B) Colon
of mice (Notch-1ΔIEC and Notch-1F/F either exposed to 2Gy radiation or not (control)) was extracted and
longitudinal dissected. Mucosal scrapings were taken to analyze the protein level of Nf-kB and STAT 3 to
find their association with Notch-1. Immunoblot for the expression of STAT3 with GAPDH as a loading
control shows downregulation of STAT3 during the upregulation of Notch-1 in Notch-1F/F mice. (C)
Colonoscopy images to show inflammation in colon increased slightly in Notch-1F/F mice after radiation
induced colitis but Notch-1ΔIEC mice had escalated inflammatory response. The area focused in white
squares shows shows propensity of inflammation in different groups. Scale bars, 100 μm.

Radiation-induced colitis severity was assessed by colonoscopy and colonic levels of
TNF-α, IL-6, IL-12, IL-22, and IL-10. The widely used murine colitis model, IL10−/−, has a normal
inner mucus layer in terms of thickness but produces a mucus structure that is penetrable to
bacteria [59]. It suggests the role of cytokines in mediating the intestinal barrier. To decipher
how Notch-1 modulates the expression of cytokines, we performed qPCR for different proinflammatory and anti-inflammatory cytokines. Compared with the control Notch-1F/F H2O
group, the mRNA levels of IL-6, IL-22, IL-12, TNFα, and IL-10 were significantly elevated in
colonic tissues of mice with radiation-induced colitis (Fig. 14A). According to previous research,
Notch signaling is also necessary to produce IL-22 [60]. Interestingly, the expression of IL-10, an
anti-inflammatory cytokine, also increased in mRNA QPCR experiments following the radiation
induction on day 7. The concentration of pro-inflammatory cytokines mentioned above was
drastically increased in the Notch-1F/F 2Gy group compared to the Notch-1ΔIEC 2Gy group. This
confirms that Notch-1 spikes the pro-inflammatory cytokines.
Notch/STAT3 is a universal molecular switch regulating anti-inflammatory functions in
chronic inflammation [42]. Notch signaling integrates STAT3-dependent inflammatory cytokine
cues to induce IL-10 expression selectively. To test this, we checked immunoblotting data,
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which clearly shows the tapering of STAT 3 protein in the presence of Notch-1, which results in
less IL-10 production in the presence of Notch-1 in acute colitis (Fig. 14B).
To investigate the effect of radiation exposure on the colon of Notch-1ΔIEC and Notch1F/F mice, we visualized mucosal inflammation by colonoscopy. Inflammation in the colon for
different groups showed a similar tendency depicted by the rise in cytokines. (Fig. 14C). Thus,
our data confirm that inhibiting the expression of Notch-1 in the later stages of UC could inhibit
the overwhelming inflammatory response, which is partly responsible for the treatment of UC.
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2.3.10 Gut Microbiota Population is Altered in Conditional Notch-1 Deficient Colon

Figure 15. Notch-1 affects gut microbiota composition.
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(A) mRNA expression of different commensal bacteria by RT-qPCR, including total bacterial population
16SrRNA, Firmicutes, Bacteroidetes sp., Fusobacterium, Akkermensia (A. muciniphila), and Enterococcus
faecalis (E. faecalis) was examined by qRT-PCR in colonic mucosa from 8-week old mice after seven day
recovery from radiation injury. (B) RT-qPCR for MUC2 gene. Data is depicted as fold change. Data were
normalized to the expression of 36BR (housekeeping gene). Data were expressed as mean ± SD (n=5) of
three independent experiments. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, vs. radiation
groups (one-way ANOVA test followed by Dunnett test).

Notch-1 has a trophic effect on the epithelial barrier, contributing to their direct
inhibitory effect on bacterial invasiveness. In previous studies, mouse models with spontaneous
colitis have an inner mucus layer that is penetrable to bacteria [61]. Although the cause of the
dysbiosis is uncertain, we hypothesized that the enhanced mucus production in Notch-1ΔIEC
mice colon could result in changes in the mucus-associated flora, thereby allowing bacteria with
the increased inflammatory potential to become more pronounced and contribute to the
development of chronic inflammation. To investigate this, we performed mRNA analysis for the
16S gene, which depicted an expected reduction in bacterial species in the mucosal scrapings of
colon radiation-induced colitis mice on Day 7 post-radiation. Bacteroidetes, Fusobacterium, and
Enterococcus faecalis abundance increased significantly following radiation injury in Notch-1F/F
mice (Fig. 15A). However, the most abundant mucolytic genera, Akkermansia muciniphila,
remained higher in the Notch-1ΔIEC irradiated group. Firmicutes abundance plummeted after
radiation in both Notch-1F/F and Notch-1ΔIEC mice. RT-qPCR also quantified Muc2 gene
expression in all the groups of Notch-1F/F and Notch-1ΔIEC mice (with/ without radiation),
confirming the trends formerly pronounced, statistically significant in RT-qPCR data of different
bacterial phyla (Fig. 15B). In sum, these data suggest that disruption in the luminal environment
of Notch-1 deficient mice contributes to an alteration in the composition of bacterial flora
associated with the colonic mucosa, likely initiating the pronounced inflammation.
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2.3.11 Notch Signaling Regulates the Motility and Proliferation of Intestinal Epithelial
Cells
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Figure 16. In vitro wound healing assay to access Notch-1 role in wound recovery in colitis.
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(A) Immunoblotting of the cells (HCT116 and Caco-2) as controls and HCT116 transfected by NICD1 or
empty plasmid using Ab against NICD1. Data are representative of three independent experiments. (B)
Illustration of plasmid used in transfection experiments(C) Transfection efficiency showed via EGFP
expression in fluorescence microscope at different time intervals (24, 48, and 72 hr). Scale bars, 100 μm.
(D) Representative images of cell filling gap via cell proliferation at 24hr, 48hr, and 72hr in control
(vehicle), Empty vector, and NICD1 plasmid conditions were subjected to scratch wounding. Scale bars,
100 μm. (E) Quantitative data is shown in area of wound recovery. Percentages were expressed as mean
± SD of three independent experiments. (XY table- area under the curve) * p < 0.05, ** p < 0.01 (0hr,
24hr, 48hr and 72 hr). (F) Representative images for cell migration after transfection of control (vehicle),
Empty vector, and NICD1 plasmid at 24hr and 48hr after wounding. Images of the wound area were
acquired, and the number of cells per field that had migrated into the cell-free wound zone was
determined for each culture. Scale bars, 100 μm. (G) Quantitative data on cell migration, using Image J
software to calculate wound width in percentage expressed as mean ± SD of three independent
experiments. (XY table- area under the curve) * p < 0.05, ** p < 0.01 (0hr, 24hr, 48hr and 72 hr).

To examine if Notch-1 helps in wound healing in colitis. We performed an in vitro wound
healing scratch assay. Studying the collective proliferation of cells in a two-dimensional
confluent monolayer in highly controlled in vitro conditions allows us to investigate the role of
NICD1 or lack thereof in wound healing. For the assay of HCT116 cells, colon human carcinoma
cells were cultured in 6 well plates and incubated for 24 hrs. When cells were 70-90%
confluent, cells were then transfected with hNICD1 cloned into the pCMV-IRES2-EGFP vector or
without hNICD1 (Empty vector). (Fig. 16B) represents the backbone of the plasmid pCMV-IRES2EGFP. (Fig. 16C) The transfection efficiency was visualized by fluorescence microscopy,
detecting the GFP signal associated with the plasmid containing the EGFP encoding gene. (Fig.
16A) The presence of the NICD1 gene was also portrayed by performing an immunoblotting
experiment after transfection with NICD1 and Empty vector plasmids. The controls were
HCT116, and Caco-2 cell lines, which describe the presence of basal level Notch-1 in Caco-2 cells
as opposed to HCT116; therefore, all the expression shown in immunoblot was using the
plasmids are purely because of externally provided NICD1. Post 24 hr of transiently transfecting
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the plasmids into HCT116 cell line using Lipofectamine transfecting reagent. A linear thin
scratch "wound" (creating a gap) in a confluent cell monolayer was made using a pipette tip (Fig
16D). Subsequently, images were captured at 24, and 48 hr regular time intervals by using a
fluorescence microscope. (Fig. 16D) depicts the images of the scratch assay in three conditions,
control had only cells and transfecting reagent, NICD1 had pCMV-IRES2-hNICD1-EGFP vector
containing notch intracellular domain gene, and Empty vector pCMV-IRES2-EGFP, which had
only EGFP expression without gene of interest. It was observed visually after taking pictures
with a fluorescence microscope that NICD1 transfected cells were proliferating faster to close
the scratch wound, which shows that Notch-1 mediates wound healing. (Fig. 16E) To quantify
the effect of NICD1 in accelerating wound healing via increased proliferation, we calculated the
wound width area that kept decreasing with time. ImageJ software was used to calculate the
proliferation efficiency. The wound area is illustrated in percentage closure which dropped the
most in NICD1 transfected wells [62].
To study Notch-1 role in migration and reduce the risk of cell proliferation confounding
the study of migration, a low dose of the proliferation inhibitor mitomycin C was used. 24 hr
after transfection, cells were treated with mitomycin C (10 µg/ml) for 3 hours and washed
three times with PBS to inhibit cell proliferation. Mitomycin C is an antitumor antibiotic that
inhibits DNA synthesis [63]. Low serum concentrations in cell medium (serum starvation) are
the most common method to suppress cell proliferation in wound healing assays. (Fig. 16F) The
cell monolayer was then subjected to a mechanical scratch-wound induced using a sterile
pipette tip. Cells were cultured for an additional 24 hours in a serum-free basal medium. Cells
in the injury area were visualized under a fluorescence microscope. The wound area was
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calculated by manually tracing the cell-free area in captured images using the ImageJ public
domain software. (Fig. 16G) The migration rate was expressed as the change in the wound area
over time. To quantify the migration capacity in different conditions, the wound width was
expressed as the percentage of area reduction or wound closure. The closure percentage will
decrease as cells migrate over time.
2.4 Discussion
The colonic epithelium comprises three lineages of cells that arise from intestinal stem
cells which are enterocytes, goblet cells, and Paneth like cells [64] . Recent studies have shown
that various signals such as Wnt, Sonic hedgehog, bone morphogenetic protein, and Notch
interact with the stem and progenitor cells of the intestinal epithelia to finely regulate the
expansion and the cell fate decision of IECs for the maintenance of the intestinal epithelia [65].
In this study, we investigated the pathway by which Notch-1 could attenuate inflammation
during colitis recovery phase by inducing differentiation and proliferation of colonic epithelium
resulting in faster wound healing and thereby restoring the epithelial-mucosal homeostasis.
Numerous studies have confirmed that depletion of Hes1 is associated with significant
increases in the secretory lineage IECs [66]. We noticed the same in immunoblot data where
Hes-1 expression was diminished from Notch-1ΔIEC mice. Further studies have shown that the
activation of Notch promoted the proliferation of crypt progenitor cells and directed their cell
fates toward absorptive but not secretory lineage cells [27, 67, 68]. Once stimulated, activation
of Notch upon ligand binding promotes the expression of Hes-1 (Hairy and Enhancer-of-split-1),
which then would suppress downstream ATOH1, resulting in an increase of enterocytes in
parallel with restricting differentiation into goblet cells and MUC2 expression. Goblet cells are
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columnar epithelial cells specializing in the secretion of high-molecular-weight glycoproteins,
called mucins. Mucin 2 (MUC2), synthesized by goblet cells, is the predominant structural
component of the intestinal mucus layer that functions as a barrier to protect the epithelium
[69, 70]. After performing AB-PAS staining, we noticed goblet cells decrease in number or are
depleted in the inflamed mucosa of Notch-1F/F mice after radiation due to high expression of
Notch-1; on the other hand, the goblet cell population was expanded in Notch-1ΔIEC mice. MUC2 expression in qPCR data showed congruent results depicting more mucin production in
Notch-1ΔIEC mice after radiation-induced colitis.
Once the epithelial layer is damaged, Notch-1 is the primary protein that supports
restoring the continuity and integrated structure of the epithelium [71]. Notch-1 is responsible
for the rapid expansion of undifferentiated IECs. Notch-1 also improves proliferation, as seen by
the upregulation of Ki67+ cells and cyclin D1expression. Cyclin D1 expression was correlated
with disease activity and cell proliferation in UC cases [66]. We observed that Ki67 and cyclin D1
expression was dominant in the crypt, where Notch expression is the highest. Ki67 expression
was restored in Notch-1F/F 2Gy mice, exhibiting the role of Notch-1 in proliferation. We further
established that during colitis, Notch-1 prefers proliferation over differentiation. This was
pointed out by the reduction of KLF5, which was evident in immunofluorescence images.
Genetic network analysis identified KLF5 as a critical transcription factor regulating intestinal
cell differentiation [66]. KLF5 also participates in the cell cycle, inducing the expression of
several cell cycle-related genes, including cyclin D1 and cyclin B [72, 73]. These data also raise
the possibility that Notch-1ΔIEC mice are defective in epithelial cell turnover and activate
apoptosis. We, therefore, performed TUNEL assay, which is the hallmark of apoptosis, i.e., DNA
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degradation. The DNA cleavage may yield DNA breaks (nicks) which can be detected by TUNEL
(TdT-mediated dUTP-X nick end labeling). To quantify the rate of colonic epithelial apoptosis,
we counted the number of apoptotic cells per crypt. Consistent with Ki67-staining data, the
number of apoptotic cells was significantly increased in the colonic epithelium of Notch-1ΔIEC
mice. These results suggest that Notch-1 helps maintain the intestinal epithelium barrier by
preventing apoptosis.
In mouse intestinal crypts, Notch signaling is an important pathway associated with
stem cell self-renewal [27, 73-76]. Accordingly, the proliferative zone of intestinal crypts
contains essential Notch pathway components, such as receptors NOTCH1, ligands DLL-1, DLL4, and JAG-1, and downstream Hes1 and Hes5 [12, 76]. To explore the role of Notch-1 in
renewing Lgr5+ stem cells, we performed an immunofluorescence staining which resulted in
decreased expression of stem cells after injury, but Notch-1F/F mice were recuperating with the
loss better than Notch-1ΔIEC mice. Notch signaling is a key mechanism that regulates the balance
between highly proliferative and relatively quiescent stem cells and activates asymmetric
division when the tissue is under stress, providing a survival strategy for maintaining
homeostasis within intestinal tissue.
Thus, these studies have suggested that Notch-1 signaling functions in the intestine
regulate differentiation and proliferation of IECs, contributing to the maintenance and the
homeostasis of the intestinal mucosa. However, the role of Notch signaling in tissue
regeneration is less understood. Damage to the intestinal epithelia is observed in various
diseases, such as acute intestinal infections, radiation injuries, or idiopathic inflammatory bowel
diseases [77]. It has been established that Reg 3α protein plays a role in tissue regeneration as a
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mitogenic and/or antiapoptotic factor [72, 73], and other Reg family proteins likely have similar
roles in inflamed tissues [71, 78-80]. These findings strongly suggest the involvement of Reg
family proteins in regenerating the inflamed colon. Here, we demonstrated that Reg 3α, 3β, and
3γ are expressed in colonic epithelial cells and that their gene expression correlates significantly
with the degree of histological damage to colonic tissue. We observed that Reg family mRNA
expression was escalated in the presence of Notch-1 in wild-type mice that were exposed to
radiation. This makes us conclude an indirect link between Notch and Reg proteins. Another
change observed in the intestine during such a regenerative process is the ectopic expression of
antimicrobial peptides by IECs. Paneth cells usually secrete peptides such as lysozymes, which
helps maintain the ideal environment for the stem and progenitor IECs. The lower expressions
of these antimicrobial peptides by IECs are frequently observed in the inflamed colonic mucosa
[81, 82]. Such expressions likely support the local immune system in providing an ideal
environment for regenerating the damaged mucosa. When we examined lysozyme expression
via immunofluorescence, it became clear that the expression of antimicrobial peptides such as
lysozymes plummeted in radiation-induced injury. It had no direct relationship with the
presence/absence of the Notch-1 gene.
Advancing on finding out indirect links between Notch and wound healing, we
discovered that studies of the mechanism responsible for regulating the expression
of Reg family genes have shown that cytokines and growth factors play a critical role in the
upregulation of Reg proteins, which is evident in injured mucosa [82-84]. In addition, previous
studies have demonstrated that several signaling pathways and cytokines cascade with the
Notch pathway to mediate epithelial regeneration, such as interleukin-22 (IL-22) and tumor
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necrosis factor-α (TNFα) [85, 86]. After performing a qPCR for respective cytokines, we spotted
a similar trend where TNFα and IL-22, a known anti-inflammatory cytokine, had been
upregulated in Notch-1F/F radiation-induced colitis mice. Pro-inflammatory cytokines like IL-1β,
IL-6, IFN-γ, and IL-12 were upregulated in radiation injury in Notch-1ΔIEC mice compared to
Notch-1F/F mice. IL-10 and IL-22, known for anti-inflammatory properties, had higher gene
expression in Notch-1F/F mice under stress. Further supports that Notch-1 reduces inflammation
and helps restore epithelial homeostasis in colon.
Moreover, it is reported that the Notch signaling pathway contributes to maintaining
tight junctions and adherens junction proteins in mice. In response to inflammation, altered
claudin protein profiles in the TJ are associated with perturbed paracellular movement of fluid
and solutes, which is reflected in the overall change in epithelial barrier function.
Ahmed et al. experimented by infecting the colon with Citrobacter rodentium and the
absence of the Notch pathway. This resulted in compromised tight and adherens junctions,
consequently leading to increased permeability of epithelial cells during inflammation [87]. We
tested the immunoblot expression of multiple TJs, including claudin-1, claudin-2, ZO1, and
occludin. Replacement of barrier-forming claudin-1 with pore/channel-forming claudin-2
ultimately influenced ion and fluid movement across cells. Expression of claudin-2 increased in
the Notch-1ΔIEC mice after radiation. Claudin-2 is restricted to the colonic crypt in the
physiological state but extends beyond crypt-base proliferative cells in case of colitis. This
results in poor epithelial barrier and inflammation due to a leaky gut.
We hypothesized that the enhanced mucus production in Notch-1ΔIEC mice in the colon
could result in changes in the mucus-associated flora, thereby allowing surface-associated
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bacteria with the increased inflammatory potential to become permanently established and
contribute to the development of chronic inflammation. Frequent crypt necrosis was observed
in the colonic mucosa of Notch-1ΔIEC mice, suggesting bacterial infection. To investigate this, we
performed qPCR with mucosal scrapings of Notch-1F/F and Notch-1ΔIEC mice in different
conditions (water and radiation injury). A meaningful difference was found in the bacterial
colonies where Bacteroidetes sp, Fusobacterium, and E. faecalis increased significantly
following radiation injury in Notch-1F/F mice. Firmicutes are far more established in a healthy
colon. However, the most abundant mucolytic genera, Akkermansia was increased in Notch1ΔIEC mice, understandably so because A.muciniphila feeds on mucus, and due to high
expression of Notch-1 in Notch-1F/F mice, MUC2 is conversely diminished. In sum, these data
suggest that disruption in the luminal environment contributes to an alteration in the
composition of bacterial flora associated with the colonic mucosa, which likely manifests
inflammation. Lack of Dll1, but not loss of Dll4 or Jagged1, causes an escalation in goblet cell
numbers in the colon, suggesting that Dll1 is the most essential Notch receptor ligand in the
crypt [75]. We confirmed the expression of different Delta and Jag ligands in case of radiationinduced injury and discovered that DLL-1 was reduced in Notch-1, which is congruent with the
fact that DLL-1 is secreted by goblet cells and in the occurrence of inflammation goblet cells
become fewer in number. Whereas in contrast, DLL-4 was augmented in Notch-1F/F 2Gy mice.
However, there was no observable difference in the Jag-1 and Jag-2 gene expression.
Suggesting DLL-4 is the primary ligand that gets upregulated in inflammation.
To bolster our in vivo results, we validated the results by executing in vitro assays. We
transfected HCT116 (human colon carcinoma) cells with a plasmid containing the NICD-1 gene
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and compared it with a control empty plasmid. During the migration and proliferation scratch
assays, it was depicted that cells with the NICD-1 gene were healing the wound much faster
than controls. This further confirmed formerly positioned in vivo results.
These results suggested that the activation of Notch-1 reduced the loss of TJs and
improved cell proliferation, regulated the MUC2 synthesis in epithelial cells, and regenerated
Lgr5+ intestinal stem cells in injury-induced colitis. Hence Notch-1 is the primary target to be
augmented for faster wound healing. It further confirms that the activation of Notch is critical
for the proper regeneration program in the epithelial layer and that it helps suppress goblet cell
differentiation and promote cell proliferation. Understanding the mechanisms that lead to
wound healing in IBD pathogenesis is crucial. To find new therapeutic strategies to improve
patient health, Notch-1 can serve as an excellent target.
3 CONCLUSION
In this study, we sought to explore the role of Notch-l during recovery phase after colitis,
using two different experimental models to induce colitis i.e., DSS and X-ray irradiation. We
hypothesized that Notch-l activation plays a protective role during recovery after colitis. We
generated Notch-1 conditional knockout mice directed in intestinal epithelial cells.
The first section of this dissertation focuses over the characterization of Notch-1ΔIEC
mice. We observed that the conditional deletion of Notch-l leads to higher numbers of goblet
cells and compromises epithelial crypt architecture and colonic barrier function. We also
observed that the conditional deletion of Notch-1 compromises epithelial cell differentiation
and rather induces proliferation in the colon. Next, we explored if Notch-l activation mediates

NOTCH-1 MEDIATES EPITHELIAL-MUCOSAL HEALING

56

or suppresses inflammation in colitis recovery phase, using a DSS- induced colitis model as well
as radiation induced injury model. Interestingly, our results indicate that Notch-1 upregulates
both pro-inflammatory and anti-inflammatory cytokines during the recovery phase. This implies
that Notch-1 is critical in establishing the equilibrium between pro-and anti- inflammatory
cytokines to manage cytokine storm due to colitis. Our data clearly indicates that Notch-1 is
necessary to promote proliferation which is essential in healing of colitis wounds faster. Notchl is known for its role in colonic stem renewal, progenitor-cell fate determination, and tissue
homeostasis. Using radiation-induced colitis recovery model and HCT116 cell line transfected to
overexpress NICD, we showed that Notch-1 indeed promotes wound healing in the recovery
phase following acute colitis. The balanced dualism of the Notch signaling by promoting cell
proliferation/ migration as well as preferred cell differentiation to enterocytes are established
in our study. The Notch system is implicated in both; (A) pathological processes of inflammatory
diseases including, but not restricted to, cancer progression and metastasis, as well as,
autoimmune diseases, acute and chronic inflammation and (B) homeostatic mediation as organ
development and function, and immune cells differentiation and activation.
Our rationale to consider Notch-1 as therapeutic option is based on our findings that
Notch-1 is necessary and beneficial for active healing after colitis. This may open new doors for
treatment and managing the inflammation for a range of diseases. Benefits of focusing on
Notch pathway is that other signaling pathways rely on enzymatic signal amplification, Notch
signaling does not, but rather relies on stoichiometric interactions between elements of the
pathway [88]. Thus, signal intensity can be revised precisely by cellular regulatory mechanisms.
The downstream effects of Notch activation are in general dose dependent. This implies that
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complete shutdown of the pathway may not be necessary to achieve a therapeutic effect [89].
Added key feature is that the half-life of the active form of Notch (NICD) in the nucleus is short,
which is important for controlling Notch signaling [90]. Inherently, Notch signal is a transient,
short pulse of gene regulation [90]. This implies that instead of sustained inhibition intermittent
inhibition could be sufficient to obtain a therapeutic benefit, making sure that Notch-1 signaling
is active during the recovery phase.
Noticeably, the effect of Notch-1 is context dependent. This means that Notch signals
trigger distinct responses in different cell types at different time points, and that systemic
inhibition of Notch signaling is not possible due to physiological functions served by the
activation of Notch. Therefore, for therapeutic utility it is essential to determine expression
level at a particular site and timing of Notch activation or inhibition that is sufficient to attain
efficacy in disease control without causing any adverse side-effects. Combined with increasing
evidence for aberrant regulation of Notch signaling in several inflammatory disorders, this
makes Notch ligands and receptors possibly attractive therapeutic options.

Table 2. Antibodies against the Notch system used in animal studies.
Adapted from (Review article Front. Immunol., 12 April 2021. Targeting the Notch Signaling Pathway in
Chronic Inflammatory Diseases)

To date, no compounds interfering with the Notch signaling are approved for patients
with inflammatory diseases, neither have any reached clinical trials. Clinical studies inhibiting
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the Notch system have so far focused on cancer, although it’s potential in chronic inflammatory
diseases such as IBD will be beneficial. Until now pan-Notch inhibitors, Notch receptor and
ligand subtype-specific mAbs are designed with an extensive overview of ongoing and
completed clinical studies stratifying Notch targeting strategies in patients with cancer have
been reported [90]. Based on the available preclinical data from mouse models of
inflammation, we propose that modulating the Notch signaling can be an attractive therapeutic
option in IBD. In conclusion, our results could further be translated to a potential therapeutic
solution for IBD patients. Knowing the fact that Notch-l activation is context dependent as well
as disease severity dependent, our study shows that during the recovery after colitis, Notch-1 is
advantageous specifically for healing of wounds due to regeneration and proliferation of
intestinal epithelial cells.
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